Antiangiogenic therapy and tumor progression
Open Access
- 1 January 2004
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 5 (1) , 13-17
- https://doi.org/10.1016/s1535-6108(03)00336-2
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- Oxygen sensitivity severely limits the replicative lifespan of murine fibroblastsNature Cell Biology, 2003
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- Disabling Abl—Perspectives on Abl kinase regulation and cancer therapeuticsCancer Cell, 2002
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Hypoxia-inducible Factor-2α (HIF-2α) Is Involved in the Apoptotic Response to Hypoglycemia but Not to HypoxiaJournal of Biological Chemistry, 2001
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- Benign-to-Malignant B16 melanoma Progression Induced in Two Stages In Vitro by Exposure to HypoxiJNCI Journal of the National Cancer Institute, 1994
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971